The groundbreaking treatment of the medication represents a exciting development in the care of type 2 diabetes. Distinct from existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment